[HTML][HTML] 2021 年新冠病毒变异, 跨种传播及疫苗和药物研究热点回眸
杨婧， 荣文婉， 桓瑜， 龚玉环， 毕玉海 - 科技导报, 2022 - kjdb.org
概括了新冠病毒主要变异毒株的分类, 时空分布和流行动态, 以及关键变异位点和其对病毒生物
学特性的影响; 阐述了2021 年新冠病毒基因进化起源研究进展和新冠病毒在人和动物间跨种 …
学特性的影响; 阐述了2021 年新冠病毒基因进化起源研究进展和新冠病毒在人和动物间跨种 …
新型冠状病毒的起源追溯与探讨
陈国民 - Clinical Medication Journal, 2020 - 万方数据资源系统
本文以2019 年末在武汉发生的新型冠状病毒疫情为背景, 探讨了冠状病毒家族与严重急性呼吸
综合征冠状病毒2 (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) 的来源 …
综合征冠状病毒2 (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) 的来源 …
Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event
Background A novel coronavirus (2019-nCoV) associated with human to human
transmission and severe human infection has been recently reported from the city of Wuhan …
transmission and severe human infection has been recently reported from the city of Wuhan …
新冠病毒疫苗研发策略与进展概述
廖盼， 肖义军 - 生物学教学, 2021 - swxjx.ecnu.edu.cn
自新冠疫情暴发以来, 人类对新冠病毒疫苗的研发寄予厚望, 目前世界各国都在抓紧新冠疫苗的
研制. 本文概述了灭活疫苗, 减毒活疫苗, 腺病毒载体疫苗, 重组蛋白疫苗和核酸疫苗5 …
研制. 本文概述了灭活疫苗, 减毒活疫苗, 腺病毒载体疫苗, 重组蛋白疫苗和核酸疫苗5 …
Evolution of Virology: Science History through Milestones and Technological Advancements
K Zuo, W Gao, Z Wu, L Zhang, J Wang, X Yuan, C Li… - Viruses, 2024 - mdpi.com
The history of virology, which is marked by transformative breakthroughs, spans
microbiology, biochemistry, genetics, and molecular biology. From the development of …
microbiology, biochemistry, genetics, and molecular biology. From the development of …
[HTML][HTML] COVID-19—2021: A new, less predictable phase of the pandemic
J Farrar - China CDC Weekly, 2021 - ncbi.nlm.nih.gov
It is just over a year ago that what we now know as coronavirus disease 2019 (COVID-19)
first emerged in Wuhan, China (1). In twelve short months every village, every city in every …
first emerged in Wuhan, China (1). In twelve short months every village, every city in every …
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions
MP Jogalekar, A Veerabathini… - … Biology and Medicine, 2020 - journals.sagepub.com
Novel 2019 coronavirus has created havoc across the globe since its emergence in
December 2019 in Wuhan, China, and fast spreading potential. While we were able to …
December 2019 in Wuhan, China, and fast spreading potential. While we were able to …
[PDF][PDF] New corona virus: is just a tip of iceberg?
A Narwat, S Rani, G Bhutani, R Saini… - International Journal of …, 2020 - academia.edu
The world is again experiencing a global viral epidemic of zoonotic origin. As of March 30,
785807 confirmed cases of coronavirus disease 2019 (COVID-19) and 37820 deaths had …
785807 confirmed cases of coronavirus disease 2019 (COVID-19) and 37820 deaths had …
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
R Lu, X Zhao, J Li, P Niu, B Yang, H Wu, W Wang… - The lancet, 2020 - thelancet.com
Summary Background In late December, 2019, patients presenting with viral pneumonia
due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus …
due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus …
冠状病毒疫苗研究进展及2019 新型冠状病毒疫苗研发展望
张明顺， 吉宁飞 - Journal of Nanjing Medical University (Natural …, 2020 - 万方数据资源系统
2019 新型冠状病毒传染性强, 危重症发生率高, 亟需有效的防控手段. 疫苗接种是保护易感者,
阻断传染性疾病传播的重要措施. 文章总结了2002 年SARS 冠状病毒和2012 年MERS …
阻断传染性疾病传播的重要措施. 文章总结了2002 年SARS 冠状病毒和2012 年MERS …